Cargando…
Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
To better understand humoral immunity following SARS-CoV-2 infection, 114 hospitalised COVID-19 patients with antibody monitored over 8 weeks from symptom onset were retrospectively investigated. A total of 445 serum samples were assessed via chemiluminescence immunoassay. Positive rate of virus-spe...
Autores principales: | Wang, Yanan, Li, Jingjing, Li, Huijun, Lei, Ping, Shen, Guanxin, Yang, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724312/ https://www.ncbi.nlm.nih.gov/pubmed/33310664 http://dx.doi.org/10.1016/j.intimp.2020.107271 |
Ejemplares similares
-
Elevated SARS-Cov-2-Specific IgM Levels Indicate Clinically Unfavorable Outcomes in Patients with COVID-19: A Retrospective Cohort Study
por: Hu, Zhiquan, et al.
Publicado: (2021) -
Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection
por: Kučinskaitė-Kodzė, Indrė, et al.
Publicado: (2021) -
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021) -
SARS-CoV-2-specific CD4(+) T cells are associated with long-term persistence of neutralizing antibodies
por: Wang, Zhongfang, et al.
Publicado: (2022) -
Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Tian, Xiaodong, et al.
Publicado: (2021)